换一批The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
第一作者：
Paweł,Kawalec
第一单位：
Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, 20 Grzegorzecka St., 31-531, Kraków, Poland, pawel.kawalec@uj.edu.pl.
作者：
医学主题词
抗体, 单克隆(Antibodies, Monoclonal);抗风湿药(Antirheumatic Agents);关节炎, 类风湿(Arthritis, Rheumatoid);人类(Humans);炎症(Inflammation);Janus激酶类(Janus Kinases);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);吡咯类(Pyrroles);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险(Risk);治疗结果(Treatment Outcome);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.1007/s10067-013-2329-9
PMID
23877486
发布时间
2025-07-11
- 浏览37
Clinical rheumatology
1415-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
